ORIC Pharmaceuticals Inc (ORIC:NASDAQ)
$13.4 -0.02 (-0.15%)
Analysed ORIC Pharmaceuticals Inc (ORIC:NASDAQ) News Sources
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates
Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Insulet (PODD)
The Globe and Mail
Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say
The Economic Times on MSN
Cullinan Therapeutics Inc.
Barron's
India's drug regulator inspected 90% of cough syrup makers, found lapses in some, official says
The Economic Times on MSN
Indoco Remedies rises on USFDA approval for Brivaracetam oral solution
Business Standard
Indoco Remedies shares rise 7% on USFDA approval for Brivaracetam oral solution
CNBCTV18
What is the current price of ORIC Pharmaceuticals Inc (ORIC:NASDAQ)?
The current price of ORIC Pharmaceuticals Inc (ORIC:NASDAQ) is $13.4.
ORIC Pharmaceuticals Inc (ORIC:NASDAQ) absolute price change since previous trading day?
The absolute price change of ORIC Pharmaceuticals Inc (ORIC:NASDAQ) since the previous trading day is $-0.02.
ORIC Pharmaceuticals Inc (ORIC:NASDAQ) percentage price change since previous trading day?
The percentage price change of ORIC Pharmaceuticals Inc (ORIC:NASDAQ) since the previous trading day is -0.15%.
What is This Week's average sentiment score for ORIC Pharmaceuticals Inc (ORIC:NASDAQ)?
This Week's average sentiment score for ORIC Pharmaceuticals Inc (ORIC:NASDAQ) is 73 out of 100.
What is This Week's average sentiment for ORIC Pharmaceuticals Inc (ORIC:NASDAQ)?
This Week's sentiment for ORIC Pharmaceuticals Inc (ORIC:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.